Nasdaq - Delayed Quote USD

Rydex Biotechnology Inv (RYOIX)

69.84 -0.13 (-0.19%)
At close: April 24 at 6:46 PM EDT

Fund Summary

Under normal circumstances, the fund invests substantially all (at least 80%) of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations. The fund is non-diversified.

Risk Overview

Morningstar Risk Rating
Best 1Y Total Return 54.66%
Worst 1Y Total Return --
Number of Years Up 18
Number of Years Down 7

Performance & Risk

YTD Return -5.51%
5y Average Return 3.75%
Rank in Category (ytd) 88
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.78
Morningstar Risk Rating

Risk Statistics

3 Years5 Years10 Years
RYOIXCategory AverageRYOIXCategory AverageRYOIXCategory Average
Alpha -6.78 0.04 -3.85 0.03 -0.45 0.07
BETA 0.78 0.01 0.76 0.01 0.95 0.01
Mean Annual Return 0.01 0.01 0.48 0.01 0.72 0.01
R-squared 54.03 0.6 48.02 0.52 41.96 0.5
Standard Deviation 17.5 0.21 19.55 0.19 21.68 0.17
Sharpe Ratio -0.16 0.01 0.19 0.01 0.33 0.01
Treynor Ratio -5.52 0.17 2.46 0.16 5.18 0.18

Related Tickers